Cash costs seem nice, but isn't the obvious drawback here that we are still talking 600-700 thousand ounces?? It does look tempting but...
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling